| Literature DB >> 29361712 |
Yage Tian1,2, Xican Li3,4, Hong Xie5,6, Xiaozhen Wang7, Yulu Xie8,9, Chuanbing Chen10, Dongfeng Chen11,12.
Abstract
Our study explores the antioxidant and cytoprotective effects of baicalein and further discusses the possible mechanisms. A methyl thiazolyl tetrazolium (MTT) assay revealed that baicalein could considerably enhance the viability of hydroxyl radical-treated bone marrow-mesenchymal stem cells (bmMSCs) at 37-370 µM. The highest viability rate was 120.4%. In subsequent studies, baicalein was observed to effectively scavenge hydroxyl radical and PTIO• radicals, reducing Fe3+ and Cu2+ ions. In the Fe2+-chelating UV-vis spectra, mixing of baicalein with Fe2+ yielded two evident redshifts (275 → 279 nm and 324 → 352 nm) and a broad absorption peak (λmax ≈ 650 nm, ε = 1.6 × 10³ L mol-1·cm-1). Finally, we compared the Fe2+-chelating UV-vis spectra of baicalein and its analogues, including 5-hydroxyflavone, 6-hydroxyflavone, 7-hydroxyflavone, catechol, pyrogallol, and chrysin. This analysis revealed that the 4-keto group of the C-ring played a role. The 5,6,7-trihydroxy-group (pyrogallol group) in the A-ring served as an auxochrome, enhancing the absorbance of the UV-vis spectra and deepening the color of the Fe2+-complex. We concluded that baicalein, as an effective hydroxyl radical-scavenger, can protect bmMSCs from hydroxyl radical-mediated oxidative stress. Its hydroxyl radical-scavenging effects are likely exerted via two pathways: direct scavenging of hydroxyl radicals, possibly through electron transfer, and indirect inhibition of hydroxyl radical generation via Fe2+ chelation through the 4-keto-5,6,7-trihydroxy groups.Entities:
Keywords: 5,6,7-trihydroxyflavone; Fe2+-chelating; antioxidant mechanism; baicalein; bmMSCs; e-transfer
Mesh:
Substances:
Year: 2018 PMID: 29361712 PMCID: PMC6017293 DOI: 10.3390/molecules23010223
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure (A) and preferential conformation-based ball-and-stick model (B) of baicalein (5,6,7-trihydroxyflavone).
Figure 2Protective effect of baicalein toward •OH-treated bmMSCs. Cell viability was assessed using the MTT method. •OH radicals were generated by addition of FeCl2 (100 μM) followed by H2O2 (50 μM). The control group was cultured in medium only, while the model group was treated with •OH radicals. The baicalein group was treated by •OH followed by baicalein. Each value is expressed as the mean ± SD, n = 3; * Significant difference vs. model group, p < 0.05. bmMSCs, bone marrow-derived mesenchymal stem cells; MTT, methyl thiazolyl tetrazolium.
Figure 3Dose-response curves of baicalein in the •OH-scavenging assay (A) and in PTIO•-scavenging assay (B). PTIO•-scavenging assay was conducted at pH 5.0, 6.0, 7.4, 8.0, and 9.0. Trolox served as positive control. Each value is expressed as the mean ± SD, n = 3.
IC50 values of baicalein and Trolox in various assays.
| Assays | Baicalein | Trolox | Ratio value |
|---|---|---|---|
| •OH-scavenging | 93.7 ± 1.6 a | 137.6 ± 3.6 b | 1.46 |
| PTIO• scavenging * | 188.7 ± 13.1 a | 384.2 ± 23.3 b | 2.03 |
| Cu2+ reducing | 19.0 ± 0.1 a | 44.6 ± 1.5 b | 2.34 |
| FRAP | 11.1 ± 0.0 a | 12.0 ± 0.0 a | 0.96 |
IC50 value was defined as the final concentration of 50% radical-scavenging (relative reducing power), was calculated by linear regression analysis, and is expressed as the mean ± SD (n = 3). Linear regression was analyzed using Origin 6.0 professional software. The mean values with different superscripts (a or b) in the same row, are significantly different (p < 0.05). * The assay was conducted at pH 7.4. The ratio value is defined as IC50, Trolox/IC50, Baicalein. FRAP, Fe3+ reducing antioxidant power assay. PTIO•, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide radical.
Figure 4Dose-response curves of baicalein in Cu2+-reducing (A) and Fe3+-reducing (FRAP, B) assays (Values are expressed as the mean ± SD, n = 3).
Figure 5(A) UV spectra of a low-concentration of baicalein and a baicalein-Fe2+ complex; (B) vis spectra of high-concentration baicalein and the baicalein-Fe2+ complex; (C) colors of the various solutions. (① 25 mM Fe2+; ② 0.5 mM baicalein; ③ 0.5 mM baicalein + 25 mM Fe2+; ④ 0.5 mM pyrogallol; ⑤ 0.5 mM pyrogallol + 25 mM Fe2+; ⑥ 0.5 mM catechol; ⑦ 0.5 mM catechol + 25 mM Fe2+; ⑧ 0.5 mM chrysin; ⑨ 0.5 mM chrysin + 25 mM Fe2+; ⑩ 0.5 mM 5-hydroxyflavone; ⑪ 0.5 mM 5-hydroxyflavone + 25 mM Fe2+; ⑫ 0.5 mM 6-hydroxyflavone; ⑬ 0.5 mM 6-hydroxyflavone + 25 mM Fe2+; ⑭ 0.5 mM 7-hydroxyflavone; and ⑮ 0.5 mM 7-hydroxyflavone + 25 mM Fe2+. The UV spectra of a low concentration of chrysin, 5-hydroxyflavone, pyrogallol, and chrysin-Fe2+ complex are detailed in Supplementary 2. The vis spectra of ④–⑮ are detailed in Supplementary 1).
Figure 6The proposed Fe2+-chelation reaction of baicalein (including UV-vis spectra assignments).
Figure 7The structure allowing baicalein molecules to jointly chelate one Fe2+ ion [23].
Figure 8Experimental procedures for the preparation and culture of bmMSCs (A) and for the MTT assay (B).